Latest News


Research Excellence

World Spine Day: Kolling researchers challenging old concepts to improve care

World Spine Day: Kolling researchers challenging old concepts to improve care

To mark World Spine Day on October 16, the Back Pain Research team at the Kolling Institute is urging those who experience the condition to adopt the latest advice and keep moving. Spinal pain is extremely common, affecting around 800 million people globally. The condition compromises social, family and work activities, and is the main reason Australians retire involuntarily. The lower b.....
Read more

Category: Musculoskeletal Research, New Treatment, Research Excellence

Kolling teams driving world-leading research into arthritis care

Kolling teams driving world-leading research into arthritis care

A Centre for Research Excellence to improve care for inflammatory arthritis will be based at the Kolling following an exciting announcement by Health Minister Greg Hunt. The minister revealed the latest round of National Health and Medical Research Council funding, which will see $2.5 million invested in the centre and its related projects over the next five years. Professor Lyn March wi.....
Read more

Category: Funding support, Research Excellence

Kolling centre guiding gold standard rehabilitation care

Kolling centre guiding gold standard rehabilitation care

The John Walsh Centre for Rehabilitation Research has been awarded close to $10 million to help improve the lives of those living with injury-related disability. The funding has been granted by the state’s compensation agencies icare NSW and the State Insurance Regulatory Authority, continuing a 20 year research partnership. icare NSW Managing Director and CEO Richard Harding said the re.....
Read more

Category: Funding support, Research Excellence

Kolling researchers identifying COVID-19 impact on heart health

Kolling researchers identifying COVID-19 impact on heart health

The largest study of its type in Australia will investigate the impact of COVID-19 on younger patients with new trends emerging around the cardiac complications from the Delta strain of the virus. Launched last year, the AUS-COVID trial assessed more than 640 patients in 21 hospitals across Australia, recording cardiovascular complications. From this group, 125 were people were admitted .....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

World-leading research in the spotlight

World-leading research in the spotlight

The Neuroscience and Pain Research Showcase provided a timely opportunity to demonstrate the breadth of expertise across this priority research area at the Kolling. Co-ordinated by Professors Paul Glare and Lisa Harvey, the online event attracted more than 250 people. A diverse range of presentations focused on the cutting-edge research targeting mitochondrial disease, psychiatric disord.....
Read more

Category: Neuroscience and Pain Research, Research Excellence, World-leading technology

New technology holds the key to better care for whiplash injuries

New technology holds the key to better care for whiplash injuries

New research is set to revolutionise the diagnosis and treatment of whiplash injuries, one of the most common and challenging injuries following a non-catastrophic motor vehicle collision. The longitudinal study, conducted over more than five years, involved researchers from the Kolling Institute along with scientists from Northwestern University, University of Colorado and Stanford Univ.....
Read more

Category: Musculoskeletal Research, Research Excellence, World-leading technology

New fellowship to strengthen commercial research opportunities

New fellowship to strengthen commercial research opportunities

Dr Cindy Shu will have a key role in building commercial capabilities at the Kolling after receiving a fellowship from the REDI (Researcher Exchange and Development within Industry) program. The program provides financial support to Australian and international medical technology and pharmaceutical companies to bring the best talent in-house to work on priority medical research projects......
Read more

Category: Musculoskeletal Research, Research Excellence, World-leading technology

Researchers tackle one of the nation’s biggest health challenges

Researchers tackle one of the nation’s biggest health challenges

Researchers from the Kolling Institute will support an important, Australia-wide project to address the inappropriate use of medications in residential aged care. The initiative, to be co-ordinated by Monash University’s Centre for Medicine Use and Safety, has been awarded $2 million through the Medical Research Future Fund. It will see pharmacists embedded in residential aged care.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Researchers partner with industry for innovative study into osteoarthritis

Researchers partner with industry for innovative study into osteoarthritis

Regeneus, a clinical-stage regenerative medicine company, has announced an exciting research collaboration with Professor Christopher Little and the Raymond Purves Bone and Joint Research Laboratory at the Kolling Institute. The study will further explore the disease modifying effects of Progenza™ and assess its effect in modulating the inflammatory and immune responses in a pre-cl.....
Read more

Category: Musculoskeletal Research, Research Excellence

Research directs spotlight onto the effectiveness of spinal surgery

Research directs spotlight onto the effectiveness of spinal surgery

New research has found that while the majority of Australian spinal surgeons expect large improvements from common spinal procedures, they say there is only poor quality scientific evidence demonstrating the effectiveness of surgery compared with non-surgical approaches like physiotherapy. A team from the Kolling Institute’s Back Pain Research group and the University of Sydney sur.....
Read more

Category: Musculoskeletal Research, Research Excellence